EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury

Kyung An Kim, Joo Eun Lee, Ik Jun Choi, Kwan Yong Lee, Chan Joon Kim, Mahn-Won Park, Chul Soo Park, Hee-Yeol Kim, Ki-Dong Yoo, Doo Soo Jeon, Myung Ho Jeong, Kiyuk Chang

Cardiorenal Medicine · 2024

DOI: 10.1159/000538042 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Kyung An Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea, kyung…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Myocardial Infarction, Renin-Angiotensin System, Percutaneous Coronary Intervention. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renin-angiotensin system blockers (RASBs) are known to improve mortality after acute myocardial infarction (AMI). However, there remain uncertainties regarding treatment with RASBs after AMI in patients with renal dysfunction, and especially in the setting of acute kidney injury (AKI).

Methods

Patients from a multicenter AMI registry undergoing percutaneous coronary intervention in Korea were stratified and analyzed according to the presence of AKI, defined as an increase in serum creatinine levels of ≥ 0.3mg/dL or ≥ 50% increase from baseline during admission, and RASB prescription at discharge. The primary outcome of interest was 5-year all-cause mortality.

Results

In total 9,629 patients were selected for initial analysis, of which 2,405 had an episode of AKI. After adjustment using multivariable Cox regression, treatment with RASBs at discharge was associated with decreased all-cause mortality in the entire cohort (HR 0.849, CI 0.753-0.956), but not for the patients with AKI (HR 0.988, CI 0.808-1.208). In subgroup analysis, RASBs reduced all-cause mortality in patients with stage I AKI (HR 0.760, CI 0.584-0.989) but not for stage II and III AKI (HR 1.200, CI 0.899-1.601, interaction p-value 0.002). Similar heterogeneities between RASB use and AKI severity were also observed for other clinical outcomes of interest.

Conclusion

Treatment with RASBs in patients with AMI and concomitant AKI is associated with favorable outcomes in non-severe AKI, but not in severe AKI. Further studies to confirm these results and to develop strategies to minimize the occurrence of adverse effects arising from RASB treatment are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryMyocardial InfarctionRenin-Angiotensin SystemPercutaneous Coronary InterventionAngiotensin-Converting Enzyme InhibitorsHumansMaleFemaleAgedMiddle AgedRepublic of KoreaRegistriesAngiotensin Receptor AntagonistsCreatinineTreatment Outcome

Stichwörter der Autor:innen

Acute kidney injuryAcute myocardial infarctionRenin-angiotensin system blockers

Substanzen

Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCreatinine

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea, kyungahn.kim@gmail.com.
  • Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.

Zitieren

APA

Kim, K. A., Lee, J. E., Choi, I. J., Lee, K. Y., Kim, C. J., Park, M. W., Park, C. S., Kim, H. Y., Yoo, K. D., Jeon, D. S., Jeong, M. H., & Chang, K. (2024). Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury. Cardiorenal Medicine. https://doi.org/10.1159/000538042

Vancouver

Kim KA, Lee JE, Choi IJ, Lee KY, Kim CJ, Park MW, et al. Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury. Cardiorenal Medicine. 2024. doi:10.1159/000538042

BibTeX
@article{Kim2024,
  author = {Kim, Kyung An and Lee, Joo Eun and Choi, Ik Jun and Lee, Kwan Yong and Kim, Chan Joon and Park, Mahn-Won and Park, Chul Soo and Kim, Hee-Yeol and Yoo, Ki-Dong and Jeon, Doo Soo and Jeong, Myung Ho and Chang, Kiyuk},
  title = {Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury},
  journal = {Cardiorenal Medicine},
  year = {2024},
  doi = {10.1159/000538042}
}
Kostenlos starten →